SCHEMBL4617423

SCHEMBL4617423

Cc1c(C(=O)NN2CCCCC2)nc(-c2ccc(Cl)cc2Cl)n1-c1ccc(OS(=O)(=O)CCCC(C)C)cc1

nearest known ligand 0.91

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 20/20 0.91
CNR2 P34972 7/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3080646 0.95 CNR1 (1.00) CNR1CNR2
SCHEMBL3089239 0.92 CNR1 (1.00) CNR1CNR2
SCHEMBL4616800 0.91 CNR1 (1.00) CNR1CNR2
SCHEMBL3093338 0.90 CNR1 (1.00) CNR1CNR2
Hydrochloric Acid SCHEMBL4245874 0.89 CNR1 (0.98) CNR1CNR2
SCHEMBL3086130 0.89 CNR1 (0.89) CNR1CNR2
SCHEMBL3093252 0.89 CNR1 (1.00) CNR1CNR2
SCHEMBL4388985 0.89 CNR1 (0.97) CNR1CNR2
Hydrochloric Acid SCHEMBL4243899 0.89 CNR1 (0.88) CNR1CNR2
Hydrochloric Acid SCHEMBL4243002 0.88 CNR1 (0.99) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940803-A1 1,2-DIARYLIMIDAZOLES FOR USE AS CBI MODULATORS AstraZeneca AB (SE) 2008-07-09 EP claimed
WO-2007031720-A1 1,2-DIARYLIMIDAZOLES FOR USE AS CBI MODULATORS ASTRAZENECA AB (SE) 2007-03-22 WO claimed